Sarepta Therapeutics (SRPT) Gross Profit Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 75.94% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.76% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 16.94% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 2,488.21% |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn | 6,990.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,990.10% |
| Dec 31, 2025 | -91.59% |
| Sep 30, 2025 | -33.80% |
| Jun 30, 2025 | 44.02% |
| Mar 31, 2025 | -101.17% |
| Dec 31, 2024 | 25.46% |
| Sep 30, 2024 | 27.37% |
| Jun 30, 2024 | 2,781.37% |
| Mar 31, 2024 | 66.10% |
| Dec 31, 2023 | 203.04% |
| Sep 30, 2023 | 75.66% |
| Jun 30, 2023 | -106.85% |
| Mar 31, 2023 | 2,414.93% |
| Dec 31, 2022 | 72.48% |
| Sep 30, 2022 | 1.12% |
| Jun 30, 2022 | 41.76% |
| Mar 31, 2022 | -107.58% |
| Dec 31, 2021 | 89,045.56% |
| Sep 30, 2021 | 2,118.74% |
| Jun 30, 2021 | 864.85% |
| Mar 31, 2021 | 20,526.66% |
| Dec 31, 2020 | -99.89% |
| Sep 30, 2020 | -91.30% |
| Jun 30, 2020 | -83.90% |
| Mar 31, 2020 | -99.19% |
| Dec 31, 2019 | 18.61% |
| Sep 30, 2019 | 23.31% |
| Jun 30, 2019 | 17.90% |
| Mar 31, 2019 | 26.98% |
| Dec 31, 2018 | 32.66% |
| Sep 30, 2018 | 62.67% |
| Jun 30, 2018 | 93.57% |
| Mar 31, 2018 | 266.19% |